TrialProstate cancer and prostatic diseases2021

Cardiac biomarkers in patients with prostate cancer and cardiovascular disease receiving gonadotrophin releasing hormone agonist vs antagonist.

David Margel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.